Increased collaboration and lowering the barriers to finding investment are two of the most crucial goals for the global stem cell and regenerative medicine industry over the coming years if it is to translate cutting edge science into commercialised therapies that impact patients' lives. One emerging figure driving this development is the Cell Therapy Catapult, a centre of excellence for regenerative medicine.
Spearheaded by Keith Thompson, along with a highly experienced executive team, the Catapult's vision is for the UK to be a global leader in the development, delivery and commercialisation of cell therapy, where businesses can start, and confidently grow. Based in London at Guy’s Hospital, the centre plans to take products into early clinical trials, providing clinical, technical, manufacturing and regulatory expertise and access to the NHS. The Catapult's success will be reliant on a highly collaborative ethos with an ambition to grow rapidly in 2013 and beyond.
Take a look a the minute long video of the Cell Therapy Catapult at the 2013 World Stem Cells & Regenerative Medicine Congress.